Insiders · HEPA

HEPA insider transactions

Hepion Pharmaceuticals Inc. (HEPA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

HEPA insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Hepion Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.

• Danina FisherDirector, since July 2026+$10K
• KI Holdings, Ltd.10% owner, since August 2026
• Vincent S LoPrioreExecutive Chairman, Director+$750K
• Michael J. PurcellDirector, since March 2024+$150K
• Gary S. StetzInterim CEO, Director, since March 2026+$150K
• Chase LoPrioreVP, Corp. Dev., Director, since March 2026
• Sireesh AppajosyulaChief Operating Officer, Director+$150K
• James Gordon LiddyDirector, since August 2026
• Gary S. Stetz IIDirector, since July 2026+$25K
• Black Global 5 LLC10% owner, since August 2026
• Gary S JacobDirector
• Timothy M. BlockDirector
• Kaouthar LbiatiDirector, since June 2022
• John P BrancaccioChairman, Director
• Peter WijngaardDirector+$54.2K
• Robert T FosterOfficer, Director+$57.6K
• Anand ReddiDirector, since June 2022
• Arnold LippaDirector
• John T CavanOfficer+$20K
• Thomas Phd AdamsDirector

Recent Form 3, 4, and 5 filings for HEPA

• 13d
  SEC Form 4 filed by Hepion Pharmaceuticals Inc.

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 13d
  SEC Form 4 filed by Hepion Pharmaceuticals Inc.

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 13d
  SEC Form 4 filed by Hepion Pharmaceuticals Inc.

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 13d
  SEC Form 4 filed by Hepion Pharmaceuticals Inc.

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 13d
  SEC Form 4 filed by Hepion Pharmaceuticals Inc.

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 13d
  SEC Form 4 filed by Hepion Pharmaceuticals Inc.

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 13d
  SEC Form 4 filed by Hepion Pharmaceuticals Inc.

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 13d
  SEC Form 4 filed by Hepion Pharmaceuticals Inc.

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 19d
  SEC Form 3 filed by Hepion Pharmaceuticals Inc.

  3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 38d
  Director Fisher Danina bought $10,000 worth of shares (200,000 units at $0.05) (SEC Form 4)

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 54d
  New insider Ki Holdings, Ltd. claimed ownership of 10,000,000 shares (SEC Form 3)

  3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 56d
  SEC Form 4 filed by Executive Chairman Lopriore Vincent S

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 60d
  SEC Form 4 filed by Director Purcell Michael J.

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 80d
  SEC Form 4 filed by Interim CEO Stetz Gary S.

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 80d
  SEC Form 4 filed by Executive Chairman Lopriore Vincent S

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 80d
  SEC Form 4 filed by VP, Corp. Dev. Lopriore Chase

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 80d
  SEC Form 4 filed by Director Fisher Danina

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 80d
  SEC Form 4 filed by Director Liddy James Gordon

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 80d
  SEC Form 4 filed by Chief Operating Officer Appajosyula Sireesh

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 80d
  SEC Form 4 filed by Director Stetz Gary S. Ii

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 80d
  SEC Form 3 filed by new insider Liddy James Gordon

  3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 89d
  Director Stetz Gary S. Ii bought $25,000 worth of shares (500,000 units at $0.05) (SEC Form 4)

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 89d
  Interim CEO Stetz Gary S. bought $100,000 worth of shares (2,000,000 units at $0.05), increasing direct ownership by 160% to 3,250,000 units (SEC Form 4)

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 89d
  Director Purcell Michael J. bought $100,000 worth of shares (2,000,000 units at $0.05), increasing direct ownership by 160% to 3,250,000 units (SEC Form 4)

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 89d
  Chief Operating Officer Appajosyula Sireesh bought $100,000 worth of shares (2,000,000 units at $0.05), increasing direct ownership by 160% to 3,250,000 units (SEC Form 4)

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 89d
  Executive Chairman Lopriore Vincent S bought $500,000 worth of shares (10,000,000 units at $0.05) (SEC Form 4)

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 94d
  New insider Black Global 5 Llc claimed ownership of 10,000,000 shares (SEC Form 3)

  3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 122d
  SEC Form 3 filed by new insider Stetz Gary S. Ii

  3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 124d
  SEC Form 3 filed by new insider Fisher Danina

  3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 167d
  New insider Lopriore Chase claimed ownership of 1,250,000 shares (SEC Form 3)

  3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 196d
  Director Purcell Michael J. bought $50,000 worth of shares (1,250,000 units at $0.04) (SEC Form 4)

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 196d
  Executive Chairman Lopriore Vincent S bought $250,000 worth of shares (6,250,000 units at $0.04) (SEC Form 4)

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 196d
  Interim CEO Stetz Gary S. bought $50,000 worth of shares (1,250,000 units at $0.04) (SEC Form 4)

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 196d
  Director Appajosyula Sireesh bought $50,000 worth of shares (1,250,000 units at $0.04) (SEC Form 4)

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 236d
  SEC Form 3 filed by new insider Stetz Gary S.

  3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 236d
  SEC Form 3 filed by Hepion Pharmaceuticals Inc.

  3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 236d
  SEC Form 3 filed by Hepion Pharmaceuticals Inc.

  3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 977d
  SEC Form 4 filed by Purcell Michael J.

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 978d
  SEC Form 3 filed by new insider Purcell Michael J.

  3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 992d
  SEC Form 4 filed by Jacob Gary S

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 992d
  SEC Form 4 filed by Block Timothy M.

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 992d
  SEC Form 4 filed by Lbiati Kaouthar

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 992d
  SEC Form 4 filed by Brancaccio John P

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 1077d
  Wijngaard Peter bought $15,350 worth of shares (5,000 units at $3.07), increasing direct ownership by 111% to 9,501 units (SEC Form 4)

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 1146d
  SEC Form 4: Wijngaard Peter bought $16,841 worth of shares (3,000 units at $5.61), increasing direct ownership by 200% to 4,501 units

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 1147d
  SEC Form 4: Foster Robert T bought $8,960 worth of shares (1,600 units at $5.60), increasing direct ownership by 3% to 50,470 units

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 1148d
  SEC Form 4: Foster Robert T bought $8,640 worth of shares (1,600 units at $5.40), increasing direct ownership by 3% to 48,870 units

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 1573d
  SEC Form 3 filed by new insider Lbiati Kaouthar

  3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 1588d
  SEC Form 3 filed by new insider Reddi Anand

  3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 1999d
  SEC Form 4 filed by Lippa Arnold

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 1999d
  SEC Form 4 filed by Wijngaard Peter

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 1999d
  SEC Form 4 filed by Cavan John T

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 1999d
  SEC Form 4 filed by BRANCACCIO JOHN P

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 1999d
  SEC Form 4 filed by ADAMS THOMAS PHD

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 2090d
  SEC Form 4: Peter Wijngaard bought $22,000 worth of Common Stock (10,000 units at $2.20), increasing ownership by 50% to 30,000 units

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 2090d
  SEC Form 4: T John Cavan bought $20,000 worth of Common Stock (10,000 units at $2.00), increasing ownership by 208% to 14,800 units

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
• 2090d
  SEC Form 4: T Robert Foster bought $40,000 worth of Common Stock (20,000 units at $2.00), increasing ownership by 79% to 45,259 units

  4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)